Optimi Health Corp. (OPTH) Form 6-K — Sep 8, 2026

$OPTHForm 6-KFiled Sep 8, 2026, 8:30 AM ET0001171843-26-005914Original filing

Optimi Health Corp. (Nasdaq: OPTH, CSE: OPTI), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, announced it will participate in the H.C. Wainwright 28th Annual Global Investment Conference held September 14-16, 2026 at the Lotte New York Palace Hotel. A company presentation will be available on demand beginning Friday, September 11, 2026 at 7:00 a.m.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.